POINT 1 Study Site
"Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.
The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."